This information was published on 2026-07-09T10:59:13 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2668055 (IR 1925337) |
| (220) |
20 Apr 2026
|
| (300) |
US, 20 Nov 2025, 99507742
|
| (511) (510) |
Class 5
Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease. |
| (540) | LISRAYA |
| (550) | Word |
| (730) |
PRIOVANT THERAPEUTICS, INC.
|
Find out more about publications on the About page.